# Short and Long-term Effects of Adding Oral L-arginine to Standard Therapy in Patients With COVID-19 (SARS-CoV-2)

> **NCT04637906** · NA · UNKNOWN · sponsor: **University of Campania Luigi Vanvitelli** · enrollment: 290 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DIETARY_SUPPLEMENT:** Bioarginina®

## Key facts

- **NCT ID:** NCT04637906
- **Lead sponsor:** University of Campania Luigi Vanvitelli
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-18
- **Primary completion:** 2021-04-18
- **Final completion:** 2021-09-18
- **Target enrollment:** 290 (ESTIMATED)
- **Last updated:** 2021-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04637906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04637906, "Short and Long-term Effects of Adding Oral L-arginine to Standard Therapy in Patients With COVID-19 (SARS-CoV-2)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04637906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*